197 related articles for article (PubMed ID: 29222363)
1. Stability of a pyrimethamine suspension compounded from bulk powder.
Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
[TBL] [Abstract][Full Text] [Related]
2. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP; Johnson CE; Sudekum D; Penprase K
Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
[TBL] [Abstract][Full Text] [Related]
3. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
4. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
Cober MP; Johnson CE
Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
[TBL] [Abstract][Full Text] [Related]
5. Stability of extemporaneously prepared moxifloxacin oral suspensions.
Hutchinson DJ; Johnson CE; Klein KC
Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
[TBL] [Abstract][Full Text] [Related]
6. Stability of extemporaneously prepared cinacalcet oral suspensions.
Thomson K; Hutchinson DJ; Chablani L
Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
[TBL] [Abstract][Full Text] [Related]
7. Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP; Johnson CE; Lee J; Currie K
Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
[TBL] [Abstract][Full Text] [Related]
8. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
[TBL] [Abstract][Full Text] [Related]
9. Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE; Cober MP; Hawkins KA; Julian JD
Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
[TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneously prepared rufinamide oral suspensions.
Hutchinson DJ; Liou Y; Best R; Zhao F
Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
[TBL] [Abstract][Full Text] [Related]
11. Stability of dolasetron in two oral liquid vehicles.
Johnson CE; Wagner DS; Bussard WE
Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide stability in extemporaneously compounded oral suspensions.
Trissel LA; Zhang Y; Koontz SE
Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
[TBL] [Abstract][Full Text] [Related]
13. Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
Kabiche D; Balde IB; Majoul E; Kabiche S; Bourguignon E; Fontan JE; Cisternino S; Schlatter J
Int J Pharm Compd; 2017; 21(2):160-163. PubMed ID: 28346212
[TBL] [Abstract][Full Text] [Related]
14. Stability of an extemporaneously prepared thalidomide suspension.
Kraft S; Johnson CE; Tyler RP
Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553
[TBL] [Abstract][Full Text] [Related]
15. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
Zhang YP; Trissel LA; Fox JL
Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
[TBL] [Abstract][Full Text] [Related]
16. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
Mallett MS; Hagan RL; Peters DA
Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
[TBL] [Abstract][Full Text] [Related]
17. Stability of an extemporaneously prepared clopidogrel oral suspension.
Skillman KL; Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2010 Apr; 67(7):559-61. PubMed ID: 20237383
[TBL] [Abstract][Full Text] [Related]
18. Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.
Adin D; Johnson PR; Kim CH; Nguyenba T; Rosen S
J Vet Intern Med; 2017 Nov; 31(6):1822-1826. PubMed ID: 28913839
[TBL] [Abstract][Full Text] [Related]
19. Stability study of oral pediatric idebenone suspensions.
Schlatter J; Bourguignon E; Majoul E; Kabiche S; Balde IB; Cisternino S; Fontan JE
Pharm Dev Technol; 2017 Mar; 22(2):296-299. PubMed ID: 27583702
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Peacock GF; Sauvageot J; Hill A; Killian A
Int J Pharm Compd; 2016; 20(1):81-5. PubMed ID: 27125058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
